review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Cecilia Söderberg-Nauclér | Q60146311 |
P2860 | cites work | Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10 | Q24540441 |
Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reaction | Q24673259 | ||
Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes | Q24792319 | ||
Functional profiling of a human cytomegalovirus genome | Q28185252 | ||
Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study | Q28186001 | ||
The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP | Q28239972 | ||
Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor | Q28297700 | ||
The human cytomegalovirus gene product US6 inhibits ATP binding by TAP | Q28346022 | ||
Inflammation, atherosclerosis, and coronary artery disease | Q29547232 | ||
Human cytomegalovirus UL37 immediate-early regulatory proteins traffic through the secretory apparatus and to mitochondria | Q30881356 | ||
Great amount of C.pneumoniae in ruptured plaque vessel segments at autopsy. A comparative study with stable plaques | Q30886803 | ||
MCMV infection increases early T-lymphocyte influx in atherosclerotic lesions in apoE knockout mice | Q33184773 | ||
Exacerbation of systemic lupus erythematosus related to cytomegalovirus infection | Q33504725 | ||
Cytomegalovirus is involved in vascular pathology | Q33762118 | ||
Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein | Q33849391 | ||
Reactivation of latent human cytomegalovirus in CD14(+) monocytes is differentiation dependent | Q33852869 | ||
Cytomegalovirus-induced transendothelial cell migration. a closer look at intercellular communication mechanisms | Q33854351 | ||
Persistent cytomegalovirus infection--the etiology of Sjogren's syndrome | Q41557028 | ||
High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma | Q42445963 | ||
The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients. Boston Center for Liver Transplantation CMVIG-Study Group. Cytogam, MedImmune, Inc. Gaithersburg, Maryland. | Q42662774 | ||
Cytomegalovirus-induced CD13-specific autoimmunity--a possible cause of chronic graft-vs-host disease | Q42816212 | ||
Systemic lupus erythematosus due to Epstein-Barr virus or Epstein-Barr virus infection provocating acute exacerbation of systemic lupus erythematosus? | Q43425258 | ||
Outcome of cytomegalovirus infections in patients with inflammatory bowel disease | Q43684194 | ||
Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors | Q43769307 | ||
High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection | Q43864376 | ||
Possible triggering effect of cytomegalovirus infection on systemic lupus erythematosus | Q43887002 | ||
Statin therapy interacts with cytomegalovirus seropositivity and high C-reactive protein in reducing mortality among patients with angiographically significant coronary disease | Q44051896 | ||
Interaction of strain AD169 and a clinical isolate of cytomegalovirus with peripheral monocytes: the effect of lipopolysaccharide stimulation | Q44440990 | ||
Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells | Q44743426 | ||
Murine cytomegalovirus infection increases aortic expression of proatherosclerotic genes | Q44752443 | ||
Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome | Q45116890 | ||
Detection of herpes simplex virus, cytomegalovirus and Epstein-Barr virus DNA in atherosclerotic plaques and in unaffected bypass grafts | Q45541836 | ||
Latent Epstein-Barr virus (EBV) infection and cytomegalovirus (CMV) infection in synovial tissue of autoimmune chronic arthritis determined by RNA- and DNA-in situ hybridization | Q45659478 | ||
A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: the atherosclerosis risk in communities (ARIC) study | Q45741610 | ||
Epstein-Barr virus infection of the colon with inflammatory bowel disease | Q45749016 | ||
Mechanisms of Immunosuppression in Cytomegalovirus Mononucleosis. II. Virus-Monocyte Interactions | Q45801737 | ||
The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration | Q45863859 | ||
Stimulatory and inhibitory action of cytokines on the regulation of hCMV-IE promoter activity in human endothelial cells | Q45869823 | ||
Rat cytomegalovirus-accelerated transplant vascular sclerosis is reduced with mutation of the chemokine-receptor R33. | Q45881220 | ||
Prevention of cardiac allograft vasculopathy with Certican (everolimus): the Stanford University experience within the Certican Phase III clinical trial. | Q45933783 | ||
Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation. | Q46425724 | ||
Genetic content of wild-type human cytomegalovirus | Q47709383 | ||
Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells | Q47756263 | ||
Subclinical activation of latent cytomegalovirus (CMV) infection and anti-CMV immune response in patients with atopic dermatitis. | Q47861289 | ||
Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. | Q50649143 | ||
Association of virulent Helicobacter pylori strains with ischemic heart disease. | Q50887983 | ||
Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. | Q51012002 | ||
A high prevalence of cytomegalovirus antigenaemia in patients with moderate to severe chronic plaque psoriasis: an association with systemic tumour necrosis factor alpha overexpression. | Q52978117 | ||
A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. | Q53969958 | ||
Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18. | Q53976561 | ||
Cytomegalovirus in the pathogenesis of atherosclerosis: the role of inflammation as reflected by elevated C-reactive protein levels. | Q54071052 | ||
Cytomegalovirus stimulated mRNA accumulation and cell surface expression of the oxidized LDL scavenger receptor, CD36. | Q54697153 | ||
Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR alpha-chain. | Q54786854 | ||
Evidence for coxsackievirus infection in primary Sjögren's syndrome | Q56214373 | ||
Relevance of cytomegalovirus infection and coronary-artery remodeling in the first year after heart transplantation: a prospective three-dimensional intravascular ultrasound study | Q57004259 | ||
Epidemiology of Hepatocellular Carcinoma | Q58296509 | ||
Cytomegalovirus selectively blocks antigen processing and presentation of its immediate–early gene product | Q59098221 | ||
Chlamydia pneumoniae in atherosclerotic tissue | Q33935024 | ||
Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication | Q34021267 | ||
Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains | Q34063490 | ||
Cytomegalovirus infection and cardiac allograft vasculopathy | Q34294809 | ||
Relationship of periodontal disease and tooth loss to prevalence of coronary heart disease | Q34338930 | ||
Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation | Q34349848 | ||
Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants | Q34467148 | ||
Human cytomegalovirus persistence and latency in endothelial cells and macrophages | Q34772235 | ||
Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. | Q34858442 | ||
The human cytomegalovirus protein UL16 mediates increased resistance to natural killer cell cytotoxicity through resistance to cytolytic proteins | Q34858638 | ||
Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein | Q34868376 | ||
The role of viruses in human diabetes. | Q34961433 | ||
Vascular thrombosis and acute cytomegalovirus infection in immunocompetent patients: report of 2 cases and literature review | Q35136023 | ||
Systemic lupus erythematosus and parvovirus B-19: casual coincidence or causative culprit? | Q35148611 | ||
Cervical cancer vaccines: recent advances in HPV research | Q35163709 | ||
Prevention of Cytomegalovirus Disease in Recipients of Allogeneic Stem Cell Transplants | Q35558815 | ||
Molecular mechanisms of the modulatory effects of HCMV infection in tumor cell biology | Q35628252 | ||
Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression | Q35671858 | ||
Role of tumor cell immune escape mechanisms in cytomegalovirus-mediated oncomodulation | Q35897221 | ||
Epstein-Barr virus etiology in rheumatoid synovitis | Q36049712 | ||
Human papillomavirus (HPV) in head and neck cancer | Q36064309 | ||
Non-steroidal anti-inflammatory drugs for the prevention and treatment of cancer | Q36194125 | ||
The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. | Q36242361 | ||
Infections and autoimmune diseases | Q36309436 | ||
Virus-induced atherosclerosis | Q36341613 | ||
Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway | Q36400431 | ||
Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog | Q36400815 | ||
Cytomegalovirus encodes a potent alpha chemokine | Q36436978 | ||
A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation | Q36525307 | ||
A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. | Q36544465 | ||
Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality | Q36684512 | ||
Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10) | Q37113833 | ||
Human cytomegalovirus inhibits antigen presentation by a sequential multistep process | Q37306358 | ||
Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis | Q37346172 | ||
Human cytomegalovirus-specific CD4+-T-cell cytokine response induces fractalkine in endothelial cells | Q37596537 | ||
A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism. | Q37596973 | ||
Human cytomegalovirus immediate-early 1 protein facilitates viral replication by antagonizing histone deacetylation | Q37705024 | ||
The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study | Q37870997 | ||
Prospective study of pathogen burden and risk of myocardial infarction or death | Q37875116 | ||
Atherosclerosis in apoE knockout mice infected with multiple pathogens | Q37875166 | ||
The possible role of hepatitis A virus in the pathogenesis of atherosclerosis | Q37875339 | ||
Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease | Q37875480 | ||
Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels | Q37875829 | ||
Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic tissue | Q37876378 | ||
The role of chlamydia pneumoniae in atherosclerosis - recent evidence from animal models: response | Q37876418 | ||
Multiple infections in carotid atherosclerotic plaques | Q37877522 | ||
Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model | Q37881464 | ||
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction | Q37899465 | ||
Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection | Q38282817 | ||
The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity | Q38294399 | ||
Identification of TNF-alpha-sensitive sites in HCMVie1 promoter | Q38295836 | ||
Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB. | Q38296897 | ||
CCAAT/enhancer-binding proteins alpha and beta negatively influence the capacity of tumor necrosis factor alpha to up-regulate the human cytomegalovirus IE1/2 enhancer/promoter by nuclear factor kappaB during monocyte differentiation | Q38297466 | ||
Human cytomegalovirus infection up-regulates interleukin-8 gene expression and stimulates neutrophil transendothelial migration | Q38955639 | ||
Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells. | Q39020960 | ||
Immune Response to Herpesvirus Antigens in Adults with Acute Cytomegaloviral Mononucleosis | Q39589825 | ||
Degradation of p21cip1 in cells productively infected with human cytomegalovirus | Q39605878 | ||
Reduced expression of HLA class II molecules and Iinterleukin-10- and transforming growth factor beta1-independent suppression of T-cell proliferation in human cytomegalovirus-infected macrophage cultures | Q39606146 | ||
Control of cytomegalovirus lytic gene expression by histone acetylation | Q39646686 | ||
Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs | Q39686594 | ||
Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors | Q39732445 | ||
Microbial oncogenesis | Q39753713 | ||
Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes | Q39960937 | ||
Human cytomegalovirus proteins encoded by UL37 exon 1 protect infected fibroblasts against virus-induced apoptosis and are required for efficient virus replication | Q40489255 | ||
Cytomegalovirus infection in critically ill patients: associated factors and consequences | Q40516953 | ||
Cytomegalovirus infection with interleukin-6 response predicts cardiac mortality in patients with coronary artery disease | Q40701818 | ||
Rotavirus infections and development of diabetes-associated autoantibodies during the first 2 years of life. | Q40724749 | ||
Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke | Q40831293 | ||
Cytomegalovirus-infected neuroblastoma cells exhibit augmented invasiveness mediated by beta1alpha5 integrin (VLA-5). | Q40869551 | ||
A novel link between stress and human cytomegalovirus (HCMV) infection: sympathetic hyperactivity stimulates HCMV activation | Q40870818 | ||
Human cytomegalovirus strain-dependent changes in NK cell recognition of infected fibroblasts. | Q40884145 | ||
The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis | Q40899518 | ||
Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. | Q40900792 | ||
Human cytomegalovirus infection of endothelial cells triggers platelet adhesion and aggregation | Q40975553 | ||
Development of a model for cytomegalovirus infection of oligodendrocytes. | Q41076349 | ||
The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells | Q41116878 | ||
Identification of the human cytomegalovirus G protein-coupled receptor homologue encoded by UL33 in infected cells and enveloped virus particles. | Q41154595 | ||
Cytomegalovirus reactivation and tumour necrosis factor | Q41493217 | ||
Increased levels of sequence-specific DNA-binding proteins in human cytomegalovirus-infected cells | Q41507865 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | inflammation | Q101991 |
Cytomegalovirus | Q6946 | ||
P304 | page(s) | 219-246 | |
P577 | publication date | 2006-03-01 | |
P1433 | published in | Journal of Internal Medicine | Q6295387 |
P1476 | title | Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? | |
P478 | volume | 259 |
Q59357092 | Absence of IL-10 production by human PBMCs co-cultivated with human cells expressing or secreting retroviral immunosuppressive domains |
Q33299429 | Accurate identification of paraprotein antigen targets by epitope reconstruction |
Q39868592 | Activation of telomerase by human cytomegalovirus |
Q28304034 | Active cytomegalovirus infection in aortic smooth muscle cells from patients with abdominal aortic aneurysm |
Q90599927 | Aging-associated latent herpes viral infection in normal Japanese individuals and patients with Werner syndrome |
Q43019131 | Alteration of lipid metabolism in cells infected with human cytomegalovirus |
Q37508272 | An Attenuated CMV Vaccine with a Deletion in Tegument Protein GP83 (pp65 Homolog) Protects against Placental Infection and Improves Pregnancy Outcome in a Guinea Pig Challenge Model |
Q92815075 | An Influenza Virus Hemagglutinin-Based Vaccine Platform Enables the Generation of Epitope Specific Human Cytomegalovirus Antibodies |
Q37127280 | An attenuated cytomegalovirus vaccine with a deletion of a viral chemokine gene is protective against congenital CMV transmission in a guinea pig model |
Q99712595 | Antiphospholipid antibody syndrome with thrombotic splenic infarcts associated with acute cytomegalovirus infection |
Q33293658 | Antisense transcription in the human cytomegalovirus transcriptome |
Q92886431 | Are children with protein-losing enteropathy after the Fontan operation at increased risk of cytomegalovirus enteropathy? A report of two cases |
Q40107027 | Association between high cytomegalovirus antibody titers and blood pressure in the adult Kazakh and Han Chinese populations |
Q30251777 | Association of cytomegalovirus infection with hypertension risk: a meta-analysis |
Q47564282 | Breast Cancer Association with Cytomegalo Virus-A Tertiary Center Case-Control Study |
Q33903685 | Breast cancer, cytomegalovirus and Epstein-Barr virus: a nested case-control study |
Q64940781 | CD46 facilitates entry and dissemination of human cytomegalovirus. |
Q42227108 | CD4:8 ratio >5 is associated with a dominant naive T-cell phenotype and impaired physical functioning in CMV-seropositive very elderly people: results from the BELFRAIL study. |
Q35811921 | CMVpp65 Vaccine Enhances the Antitumor Efficacy of Adoptively Transferred CD19-Redirected CMV-Specific T Cells. |
Q34360247 | Can we build it better? Using BAC genetics to engineer more effective cytomegalovirus vaccines |
Q48305722 | Colonic perforation due to severe cytomegalovirus disease in granulomatosis with polyangiitis after immunosuppression. |
Q37406553 | Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis |
Q24632103 | Consensus on the role of human cytomegalovirus in glioblastoma |
Q92644819 | Cx43 and NMDA receptors changes in UL122 genetically modified mice hippocampus: a mechanism for spatial memory impairment |
Q38791353 | Cytomegalovirus Vaccines: Current Status and Future Prospects. |
Q42144694 | Cytomegalovirus and tumors: two players for one goal-immune escape |
Q34179430 | Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up |
Q26996612 | Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options |
Q36318051 | Cytomegalovirus occurrence in chronic periodontitis and in carcinoma of the cervix: an exploratory study |
Q44943833 | Cytomegalovirus prostatitis: a series of 4 cases |
Q35086196 | Cytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges. |
Q36341023 | Cytomegalovirus seropositivity is associated with glucose regulation in the oldest old. Results from the Leiden 85-plus Study |
Q33702990 | Cytomegalovirus vaccine development |
Q42380888 | Cytomegalovirus vaccines under clinical development |
Q33562231 | Cytomegalovirus-induced gammadelta T cells associate with reduced cancer risk after kidney transplantation |
Q59359836 | Cytomegalovirus: Shape-Shifting the Immune System |
Q38053067 | Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology |
Q38100041 | Desirability and feasibility of a vaccine against cytomegalovirus |
Q92288336 | Detection and genotyping of CMV and HPV in tumors and fallopian tubes from epithelial ovarian cancer patients |
Q34612095 | Detection of circulating hcmv-miR-UL112-3p in patients with glioblastoma, rheumatoid arthritis, diabetes mellitus and healthy controls |
Q34402501 | Detection of human cytomegalovirus in different histological types of gliomas |
Q34712949 | Detection of human cytomegalovirus in normal and neoplastic breast epithelium |
Q37574334 | Developing a Vaccine against Congenital Cytomegalovirus (CMV) Infection: What Have We Learned from Animal Models? Where Should We Go Next? |
Q36757818 | Development of a high-throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies |
Q26863724 | Direct and Indirect Effects of Cytomegalovirus-Induced γδ T Cells after Kidney Transplantation |
Q35506920 | Discordant humoral and cellular immune responses to Cytomegalovirus (CMV) in glioblastoma patients whose tumors are positive for CMV. |
Q37997733 | Diverse immune evasion strategies by human cytomegalovirus |
Q40104771 | Does Regular Exercise Counter T Cell Immunosenescence Reducing the Risk of Developing Cancer and Promoting Successful Treatment of Malignancies? |
Q39705966 | Does cytomegalovirus infection contribute to socioeconomic disparities in all-cause mortality? |
Q42244894 | Does the existence of HCMV components predict poor prognosis in glioma? |
Q28533839 | Dual analysis of the murine cytomegalovirus and host cell transcriptomes reveal new aspects of the virus-host cell interface |
Q34713776 | Elongin B-mediated epigenetic alteration of viral chromatin correlates with efficient human cytomegalovirus gene expression and replication |
Q57281000 | Epstein-Barr virus, but not human cytomegalovirus, is associated with a high grade human papillomavirus-associated cervical lesions among women in North Carolina |
Q33836696 | Evaluation of human cytomegalovirus antigen expression in invasive breast carcinoma in a population of Iranian patients. |
Q44311682 | Evidence for positive selection in the extracellular domain of human cytomegalovirus encoded G protein-coupled receptor US28. |
Q89977247 | Factors in Oncogenesis: Viral Infections in Ovarian Cancer |
Q58598685 | FoxO1 Suppresses Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication and Controls Viral Latency |
Q39153890 | Frequent detection of human cytomegalovirus in neuroblastoma: a novel therapeutic target? |
Q36517126 | Guinea Pig Cytomegalovirus (GPCMV): A Model for the Study of the Prevention and Treatment of Maternal-Fetal Transmission |
Q40877837 | HCMV Induces Macropinocytosis for Host Cell Entry in Fibroblasts |
Q34631652 | HCMV pUS28 initiates pro-migratory signaling via activation of Pyk2 kinase |
Q37611836 | HCMV reprogramming of infected monocyte survival and differentiation: a Goldilocks phenomenon |
Q35868670 | HCMV-encoded UL128 enhances TNF-α and IL-6 expression and promotes PBMC proliferation through the MAPK/ERK pathway in vitro |
Q40081161 | High anti-human cytomegalovirus antibody levels are associated with the progression of essential hypertension and target organ damage in Han Chinese population |
Q35028835 | High prevalence of human cytomegalovirus in brain metastases of patients with primary breast and colorectal cancers |
Q34602649 | High prevalence of human cytomegalovirus proteins and nucleic acids in primary breast cancer and metastatic sentinel lymph nodes |
Q41953597 | Human CMV infection induces 5-lipoxygenase expression and leukotriene B4 production in vascular smooth muscle cells |
Q36535574 | Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and beta1 and beta3 integrins |
Q46048442 | Human Cytomegalovirus Encoded miR-US25-1-5p Attenuates CD147/EMMPRIN-Mediated Early Antiviral Response |
Q39100413 | Human Cytomegalovirus Requires Epidermal Growth Factor Receptor Signaling To Enter and Initiate the Early Steps in the Establishment of Latency in CD34+ Human Progenitor Cells. |
Q37548510 | Human Cytomegalovirus US28: a functionally selective chemokine binding receptor |
Q38732318 | Human Cytomegalovirus miR-UL148D Facilitates Latent Viral Infection by Targeting Host Cell Immediate Early Response Gene 5. |
Q38562379 | Human cytomegalovirus US28 facilitates cell-to-cell viral dissemination |
Q36695499 | Human cytomegalovirus glycoprotein UL141 targets the TRAIL death receptors to thwart host innate antiviral defenses. |
Q42274183 | Human cytomegalovirus immediate early proteins promote degradation of connexin 43 and disrupt gap junction communication: implications for a role in gliomagenesis |
Q47548990 | Human cytomegalovirus in high grade serous ovarian cancer possible implications for patients survival |
Q42242369 | Human cytomegalovirus induces upregulation of arginase II: possible implications for vasculopathies |
Q40221683 | Human cytomegalovirus infection alters PC3 prostate carcinoma cell adhesion to endothelial cells and extracellular matrix |
Q42531590 | Human cytomegalovirus infection of M1 and M2 macrophages triggers inflammation and autologous T-cell proliferation. |
Q38760685 | Human cytomegalovirus may promote tumour progression by upregulating arginase-2. |
Q34059073 | Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro |
Q39652186 | Human cytomegalovirus paralyzes macrophage motility through down-regulation of chemokine receptors, reorganization of the cytoskeleton, and release of macrophage migration inhibitory factor |
Q92157207 | Human cytomegalovirus protein UL42 antagonizes cGAS/MITA-mediated innate antiviral response |
Q37976493 | Human cytomegalovirus tegument proteins (pp65, pp71, pp150, pp28). |
Q39933820 | Human cytomegalovirus-encoded miR-US25-1 aggravates the oxidised low density lipoprotein-induced apoptosis of endothelial cells |
Q92206244 | Identification of HCMV-derived T cell epitopes in seropositive individuals through viral deletion models |
Q37991389 | Immunomodulatory effects of antimicrobial agents. Part I: antibacterial and antiviral agents |
Q37065216 | Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences |
Q35574918 | Increased HCMV seroprevalence in patients with hepatocellular carcinoma |
Q43215243 | Infection with human cytomegalovirus alters the MMP-9/TIMP-1 balance in human macrophages |
Q39204170 | Infectious Agents in Bovine Red Meat and Milk and Their Potential Role in Cancer and Other Chronic Diseases |
Q38899088 | Influenza virus aggravates the ox-LDL-induced apoptosis of human endothelial cells via promoting p53 signaling |
Q54345873 | Intragraft cytomegalovirus protein expression is associated with reduced renal allograft survival. |
Q47096512 | Lack of cytomegalovirus detection in human glioma. |
Q47822364 | Latent cytomegalovirus infection and innate immune function following a 75 km cycling time trial. |
Q41927788 | Low levels of antibodies against common viruses associate with anti-citrullinated protein antibody-positive rheumatoid arthritis; implications for disease aetiology |
Q45921109 | MiR-199a-5p promotes migration and tube formation of human cytomegalovirus-infected endothelial cells through downregulation of SIRT1 and eNOS. |
Q34022257 | Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything |
Q58723116 | Monocytes and Macrophages as Viral Targets and Reservoirs |
Q57200899 | Natural killer cell-mediated response to human cytomegalovirus-infected macrophages is modulated by their functional polarization |
Q35227507 | Persistent infection, inflammation, and functional impairment in older Latinos |
Q37209892 | Persistent pathogens linking socioeconomic position and cardiovascular disease in the US. |
Q38354047 | Pharmacological and biochemical characterization of human cytomegalovirus-encoded G protein-coupled receptors |
Q40027571 | Phosphorothioate-modified oligodeoxynucleotides inhibit human cytomegalovirus replication by blocking virus entry. |
Q58593862 | Population-Wide Associations between Common Viral Pathogens and Self-Reported Arthritis: NHANES 2009-2012 |
Q47183297 | Protein and DNA evidences of HCMV infection in primary breast cancer tissues and metastatic sentinel lymph nodes |
Q36296547 | Reactivation of herpes simplex virus type 1 is associated with cytomegalovirus and age |
Q33916507 | Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency |
Q43064485 | Regulation of immune response and inflammatory reactions against viral infection by VCAM-1. |
Q37085853 | Regulation of the retinoblastoma proteins by the human herpesviruses. |
Q57417396 | Relation of high cytomegalovirus antibody titres to blood pressure and brachial artery flow-mediated dilation in young men: the Cardiovascular Risk in Young Finns Study |
Q35853687 | Relationship between functional ability in older people, immune system status, and intensity of response to CMV |
Q36950439 | Role of miRNA in carcinogenesis and biomarker selection: a methodological view |
Q37820386 | Role of tegument proteins in herpesvirus assembly and egress |
Q37470923 | Rudimentary signs of immunosenescence in Cytomegalovirus-seropositive healthy young adults |
Q37794828 | Self or nonself? That is the question: sensing of cytomegalovirus infection by innate immune receptors. |
Q30491742 | Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma |
Q26863339 | Shared mechanisms in stemness and carcinogenesis: lessons from oncogenic viruses |
Q38030241 | Social status, glucocorticoids, immune function, and health: can animal studies help us understand human socioeconomic-status-related health disparities? |
Q37395063 | Socioeconomic differentials in immune response |
Q37251214 | Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III |
Q35871129 | Socioeconomic position and inflammatory and immune biomarkers of cardiovascular disease: applications to the Panel Study of Income Dynamics |
Q35685210 | Study of viral pathogenesis in humanized mice |
Q44017355 | Synergistic enhancement of matrix metalloproteinase-9 expression and pro-inflammatory cytokines by influenza virus infection and oxidized-LDL treatment in human endothelial cells |
Q36069582 | Synthetic DNA approach to cytomegalovirus vaccine/immune therapy |
Q37183914 | Tegument proteins of human cytomegalovirus |
Q54239887 | The Human Cytomegalovirus Strain DB Activates Oncogenic Pathways in Mammary Epithelial Cells. |
Q38753361 | The absence of p53 during Human Cytomegalovirus infection leads to decreased UL53 expression, disrupting UL50 localization to the inner nuclear membrane, and thereby inhibiting capsid nuclear egress |
Q38946886 | The association between cytomegalovirus infection, obesity, and metabolic syndrome in U.S. adult females |
Q24623318 | The cytomegalovirus-encoded chemokine receptor US28 promotes intestinal neoplasia in transgenic mice |
Q91866555 | The emerging role of human cytomegalovirus infection in human carcinogenesis: a review of current evidence and potential therapeutic implications |
Q35857513 | The human cytomegalovirus virion possesses an activated casein kinase II that allows for the rapid phosphorylation of the inhibitor of NF-kappaB, IkappaBalpha |
Q38193954 | The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients |
Q46025722 | The influence of cytomegalovirus infections on patient and renal graft outcome: a 3-year, multicenter, observational study (Post-ECTAZ Study). |
Q33320187 | The landscape of human proteins interacting with viruses and other pathogens |
Q34581563 | The role of cytomegalovirus in angiogenesis |
Q24632829 | The roles of viruses in brain tumor initiation and oncomodulation |
Q58327099 | The transcriptome of human mammary epithelial cells infected with the HCMV-DB strain displays oncogenic traits |
Q38986219 | Toward an Algorithm for the Diagnosis and Management of CMV in Patients with Colitis |
Q60909604 | Transactivation of human endogenous retroviruses by tumor viruses and their functions in virus-associated malignancies |
Q38176940 | Treatment of cytomegalovirus infections beyond acute disease to improve human health |
Q58734495 | US28: HCMV's Swiss Army Knife |
Q55512532 | Unexpected role of the human cytomegalovirus contribute to essential hypertension in the Kazakh Chinese population of Xinjiang. |
Q36080805 | Vaccination with a Live Attenuated Cytomegalovirus Devoid of a Protein Kinase R Inhibitory Gene Results in Reduced Maternal Viremia and Improved Pregnancy Outcome in a Guinea Pig Congenital Infection Model |
Q37681282 | Viral epigenomes in human tumorigenesis. |
Q26745798 | Virion Glycoprotein-Mediated Immune Evasion by Human Cytomegalovirus: a Sticky Virus Makes a Slick Getaway |
Q34000058 | Viruses, microRNAs and cancer |
Q30583014 | eXamine: exploring annotated modules in networks. |
Q47552828 | miRNA-mediated targeting of human cytomegalovirus reveals biological host and viral targets of IE2. |